Silicone Breast Implant Data Requirements Questioned By Patient Groups
This article was originally published in The Gray Sheet
Executive Summary
FDA's General & Plastic Surgery Devices Panel will likely consider gel migration and "silent rupture" of silicone breast implants when reviewing Inamed's premarket application
You may also be interested in...
Inamed Silicone Implant Patient Monitoring Plans Allay Rupture Concerns
Inamed's proposal to closely follow patients implanted with silicone gel-filled breast prostheses helped sway FDA's General & Plastic Surgery Devices Panel to recommend conditional approval of the firm's PMA by a 9-6 margin
Inamed Silicone Implant Patient Monitoring Plans Allay Rupture Concerns
Inamed's proposal to closely follow patients implanted with silicone gel-filled breast prostheses helped sway FDA's General & Plastic Surgery Devices Panel to recommend conditional approval of the firm's PMA by a 9-6 margin
Anti-Silicone Implant Media Campaign, Rally Planned By Consumer Groups
A petition from Public Citizen appears to have persuaded FDA to disclose the General & Plastic Surgery Devices Panel roster nearly two weeks before the panel's review of a silicone gel breast implant premarket application